Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Edison Pharmaceuticals
Edison Pharmaceuticals
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Methergine
Methylergonovine
1982-01-01
Postpartum hemorrhage
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Vitamin e
muscular atrophy
,
spinal muscular atrophy
,
neoplasms
,
atherosclerosis
Vatiquinone
tourette syndrome
,
muscular diseases
,
inborn genetic diseases
,
homocystinuria
,
inborn errors lipid metabolism
,
hearing loss
,
noise-induced hearing loss
,
deafness
,
autistic disorder
,
autism spectrum disorder
,
pervasive child development disorders
,
parkinson disease
,
rett syndrome
,
syndrome
,
mitochondrial diseases
,
ataxia
,
friedreich ataxia
,
cerebellar ataxia
,
leigh disease
,
brain diseases
,
epilepsy
,
diffuse cerebral sclerosis of schilder
,
drug resistant epilepsy
,
melas syndrome
,
optic nerve diseases
,
emergencies
,
hereditary optic atrophy leber
Aspartame
amyotrophic lateral sclerosis
,
motor neuron disease
,
sclerosis
,
covid-19
,
respiratory distress syndrome
,
coronavirus infections
,
severe acute respiratory syndrome-related coronavirus
,
sars-cov-2
,
severe acute respiratory syndrome
,
coronavirus
,
acute lung injury
,
newborn respiratory distress syndrome
,
syndrome
,
glomerulonephritis
,
membranoproliferative glomerulonephritis
Ubidecarenone
hypercholesterolemia
Retinol
ataxia
,
friedreich ataxia
,
cerebellar ataxia
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use